ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,061.48
0.39%
US Tech 100
21,087.20
0.52%
Dow Jones
44,873.28
0.71%
Brent Oil
74.735
0.21%
Bitcoin
97,859.39
1.28%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Mineralys Therapeutics Inc (MLYS) Quote

Mineralys Therapeutics Inc

Mineralys Therapeutics Inc (MLYS)

NASDAQ
10.26
0.05
(0.49%)
Closed February 06 4:00PM
Delayed by 15 minutes
10.25
-0.01
(-0.10%)
After Hours: 7:59PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
10.26
Bid
10.00
Ask
13.85
Volume
227,300
10.17 Day's Range 10.90
8.58 52 Week Range 16.905
Market Cap
510.627M
Previous Close
10.21
Open
10.34
Last Trade
1
@
10.4
Last Trade Time
Financial Volume
$ 2,383,512
VWAP
10.4862
Average Volume (3m)
213,900
Shares Outstanding
49,768,669
Dividend Yield
-
PE Ratio
-7.10
Earnings Per Share (EPS)
-1.44
Revenue
-
Net Profit
-71.9M

About Mineralys Therapeutics Inc

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in... Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.mineralystx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Mineralys Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MLYS. The last closing price for Mineralys Therapeutics was $10.21. Over the last year, Mineralys Therapeutics shares have traded in a share price range of $ 8.58 to $ 16.905.

Mineralys Therapeutics currently has 49,768,669 shares outstanding. The market capitalization of Mineralys Therapeutics is $508.14 million. Mineralys Therapeutics has a price to earnings ratio (PE ratio) of -7.10.

Ask ADVFN Intelligence (AI)

MLYS Latest News

More News

Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on Wednesday, February 12, 2025

RADNOR, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension...

9 hours ago
GlobeNewswire Inc.

Form 8-K - Current report

February 04 2025
Edgar (US Regulatory)

Mineralys Therapeutics Completes Enrollment in Explore-CKD Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects with Stage 2 to 3b CKD and Albuminuria

RADNOR, Pa., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension...

February 04 2025
GlobeNewswire Inc.

Form 8-K - Current report

January 08 2025
Edgar (US Regulatory)

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients with Hypertension

– Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions associated with excess morbidity and mortality – –...

January 08 2025
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

November 12 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 12 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 12 2024
Edgar (US Regulatory)

Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

– Completed enrollment in pivotal Advance-HTN trial and anticipate topline data in March 2025 – – Completed enrollment ahead of schedule in pivotal Phase 3 Launch-HTN trial and anticipate...

November 11 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.434.374364191259.8310.799.56525657210.23483262CS
4-2.74-21.076923076913138.628164710.01464333CS
12-3.155-23.518449496813.41514.198.621390011.50596123CS
26-0.8-7.2332730560611.0615.258.5819044412.00563482CS
52-1.66-13.926174496611.9216.9058.5819137212.59764168CS
156-10.84-51.374407582921.121.985.8518996612.73702575CS
260-10.84-51.374407582921.121.985.8518996612.73702575CS

MLYS - Frequently Asked Questions (FAQ)

What is the current Mineralys Therapeutics share price?
The current share price of Mineralys Therapeutics is $ 10.26
How many Mineralys Therapeutics shares are in issue?
Mineralys Therapeutics has 49,768,669 shares in issue
What is the market cap of Mineralys Therapeutics?
The market capitalisation of Mineralys Therapeutics is USD 508.14M
What is the 1 year trading range for Mineralys Therapeutics share price?
Mineralys Therapeutics has traded in the range of $ 8.58 to $ 16.905 during the past year
What is the PE ratio of Mineralys Therapeutics?
The price to earnings ratio of Mineralys Therapeutics is -7.1
What is the reporting currency for Mineralys Therapeutics?
Mineralys Therapeutics reports financial results in USD
What is the latest annual profit for Mineralys Therapeutics?
The latest annual profit of Mineralys Therapeutics is USD -71.9M
What is the registered address of Mineralys Therapeutics?
The registered address for Mineralys Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Mineralys Therapeutics website address?
The website address for Mineralys Therapeutics is www.mineralystx.com
Which industry sector does Mineralys Therapeutics operate in?
Mineralys Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RFACURF Acquisition Corporation
$ 10.12
(96.12%)
22.97k
IVVDInvivyd Inc
$ 2.1001
(68.01%)
79.18M
ASSTAsset Entities Inc
$ 0.810001
(47.46%)
170.15M
ACBAurora Cannabis Inc
$ 5.37
(45.92%)
69.87M
RNAZTransCode Therapeutics Inc
$ 8.885
(44.24%)
17.23M
VLCNVolcon Inc
$ 1.82
(-43.13%)
3.88M
CSAICloudastructure Inc
$ 8.12
(-37.44%)
250.67k
CAPTCaptiVision Inc
$ 0.6819
(-35.06%)
8.88M
LRHCLa Rosa Holdings Corporation
$ 0.2695
(-31.88%)
4.46M
LYTLytus Technologies Holdings PTV Ltd
$ 0.416999
(-30.91%)
1.23M
CYNCYNGN Inc
$ 0.083
(16.90%)
449.48M
NVDANVIDIA Corporation
$ 124.83
(5.21%)
263.48M
RIMEAlgorhythm Holdings Inc
$ 0.0206
(-15.57%)
238.29M
ASSTAsset Entities Inc
$ 0.810001
(47.46%)
170.15M
BHATBlue Hat Interactive Entertainment Technology
$ 0.051599
(17.81%)
143.98M

Discussion

View Full Feed
MasterBlastr MasterBlastr 5 minutes ago
What has finally come to mind is that Trump acts like someone with little to live for, and little time left to live it.
MJAM2020 MJAM2020 8 minutes ago
https://www.ruralhealth.us/nationalruralhealth/media/documents/advocacy/advocacy%20leave-behinds%202024/2-0-rural-emergency-hospital-one-pager.pdf

imho
mj
RNVA
sage4 sage4 10 minutes ago
Thank you for sharing. The commonly estimated MC of $20 billion for AVXL doesn't acount for those countries that AI listed I think. I noticed that China and India are not included on the list while I see often Chinese scientists on the AD related articles. The populations of the two biggest countr
AVXL
silvr_surfr silvr_surfr 11 minutes ago
Wow, thank you JTFM. I have never heard of a company not disclosing good news like this. It is also another branded entry which I don't think is a coincidence. I hope any deal is worth our while since the stock has had a miserable year while the company has performed well.

The Gugge
ANIP
Wolf-man jack Wolf-man jack 11 minutes ago
CV Sciences SAYS;

https://ir.cvsciences.com/press-releases/detail/232/cv-sciences-unveils-new-aura-collection-thc-fizz-tablets
CVSI
MJAM2020 MJAM2020 13 minutes ago
Fingers crossed... https://www.minnpost.com/community-voices/2025/02/three-ways-the-trump-administration-could-reinvest-in-rural-americas-future-health-care-local-economies/

Three ways the Trump administration could reinvest in rural America’s future
To revitalize communities’
RNVA
Researchfyi Researchfyi 13 minutes ago
I’m sorry you seem to have a touch of paranoia, meaning disbelief in my opinion. But the broken record you are erroneously blaming on me is in fact the record of LQMT week after week. I realize when you carry the water for the company you have to blame someone else for their poor performance week af
LQMT
dinogreeves dinogreeves 14 minutes ago
It doesn't matter to me what it does, SMCI had pushed a press release today, enough to let traders and investment community know that they have a pulse. You must realize something, I am not here for a short term gain, my average is below 33 dollars on the shares, I bought a bought a boat load of ca
SMCI
4u2nv2 4u2nv2 14 minutes ago
You just could not resist threatening me in hopes that I would help IFUS. I was thinking I just don't want to help for free. I am never getting a check for helping. I like the science behind IFUS products but your threats on me? I just found a reason to step in and help IFUS for free. The only form
IFUS
SSKILLZ1 SSKILLZ1 15 minutes ago
Pete signs up with the Mets.... for less than a tenth of what they're paying Soto.....

Yes the gm certainly didn't overpay here. he got him at his price.

Not much roster shaking left to do for the GM.

I personally think they are done now. I don't think t
Mr. C Mr. C 16 minutes ago
The executive order mandates a decision in two weeks
TGLO
Genz2 Genz2 18 minutes ago
https://insideevs.com/news/717654/tesla-model-s-400k-mile-battery/
TSLA
shurtha2000 shurtha2000 19 minutes ago
TDS'ers FDA Fast tracked medication needed pronto/ asap - but I have a home remedy if anyone need s the recipe just e-mail me its a Jalepeno suppository gauranteed to take their minds off Trump
LuckyLovie LuckyLovie 21 minutes ago
Sorry to say Don....getting a name change with this pig is equel to a poor homeless man getting a new 5k Gucci suit to wear....in 3 weeks it will look like a dirty burlap bag on him...same with PIGLET WNFT....it's the same ceo same ole promise land/ keep your pants on story...

Many b
WNFT
XMaster2023 XMaster2023 25 minutes ago
Your boss is simply playing out his last hand. He is desperate. After shorting Trumps stock he should be leaving the country. You should follow. The only question? Where should you run to?
NWBO
lodas lodas 25 minutes ago
yo ron????.....here is an intellectual argument which no one addresses: JPM offered 8.50 per share for "lock stock and barrel, warts and all for WAMU" before the OTS stepped in and closed this company.... JPM is now selling for about 250 per share , plus or minus, which is about 30 times the off
JPM
XMaster2023 XMaster2023 25 minutes ago
Your boss is simply playing out his last hand. He is desperate. After shorting Trumps stock he should be leaving the country. You should follow. The only question? Where should you run to?
NWBO
Lionscantwinagame Lionscantwinagame 28 minutes ago
10 years in Court at minimum. The judicial system has completely turned its back on this.
FNMA
littlejohn littlejohn 29 minutes ago
Confucius say, may be SMIC pump up spillover

activity on SMCI on Wednesday due to

trader confusion on symbol...

https://www.investing.com/news/stock-market-news/chinas-smic-stock-hits-record-high-on-deepseek-ai-optimism-3852506

Nothing cha
SMCI
trunkmonk trunkmonk 29 minutes ago
This chart tells u almost everything you need to know.
XRP is gonna go a notch or 2 above Gold in the new financial system.
https://investorshub.advfn.com/uimage/uploads/2015/4/4/wh[jhexter-inverse-pyramid.jpg
XRPUSD
SSKILLZ1 SSKILLZ1 30 minutes ago
That was a great job by the GM, he realized pete had no market, and got him on a great deal. Although to be fair I didn't get why baseball didn't want to pay more for him than that. He will probably opt out after next year because I expect a nice year from pete with 100+ rbis with soto in front of h
BDEZ BDEZ 30 minutes ago
40,000 federal employees have now accepted President Trump's buyout resignation offer, per WaPo.
trunkmonk trunkmonk 32 minutes ago
the epicenter of primary wave 3 has begun, its gonna be like never before, Bit bumpkin lovers proved that even something backed by nothing can make a moon shot, Gold going to Mars, and the perfect storm and timing of it, is in the works. Nothing can stop it, either America embraces it, or China, one
ARMN

Your Recent History

NASDAQ
MLYS
Mineralys Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads